Showing posts with label DNA sequence. Show all posts
Showing posts with label DNA sequence. Show all posts

Friday, 11 December 2015

Process to Accelerate Protein Evolution

Stanford engineers invent process to accelerate protein evolution


A new tool enables researchers to test millions of mutated proteins in a matter of hours or days, speeding the search for new medicines, industrial enzymes and biosensors.

All living things require proteins, members of a vast family of molecules that nature “makes to order” according to the blueprints in DNA.






Through the natural process of evolution, DNA mutations generate new or more effective proteins. Humans have found so many alternative uses for these molecules – as foods, industrial enzymes, anti-cancer drugs – that scientists are eager to better understand how to engineer protein variants designed for specific uses.


accelerate protein, Protein, evolution, enzymes , biosensors, DNA , DNA mutations, Cells, DNA sequence

An overview of the directed evolution process using the new Stanford technique: preparing protein libraries, screening them, extracting desired cells, and then inferring their DNA sequence. (Click image to enlarge.)


Now Stanford engineers have invented a technique to dramatically accelerate protein evolution for this purpose. This technology, described in Nature Chemical Biology, allows researchers to test millions of variants of a given protein, choose the best for some task and determine the DNA sequence that creates this variant.


“Evolution, the survival of the fittest, takes place over a span of thousands of years, but we can now direct proteins to evolve in hours or days,” said Jennifer Cochran, an associate professor of bioengineering who co-authored the paper with Thomas Baer, executive director of the Stanford Photonics Research Center.


“This is a practical, versatile system with broad applications that researchers will find easy to use,” Baer said.


By combining Cochran’s protein engineering know-how with Baer’s expertise in laser-based instrumentation, the team created a tool that can test millions of protein variants in a matter of hours.


“The demonstrations are impressive and I look forward to seeing this technology more widely adopted,” said Frances Arnold, a professor of chemical engineering at Caltech who was not affiliated with the study.


Making a million mutants

The researchers call their tool µSCALE, or Single Cell Analysis and Laser Extraction.


The “µ” stands for the microcapillary glass slide that holds the protein samples. The slide is roughly the size and thickness of a penny, yet in that space a million capillary tubes are arrayed like straws, open on the top and bottom.


accelerate protein, Protein, evolution, enzymes , biosensors, DNA , DNA mutations, Cells, DNA sequence , µSCALE , u scale, microcapillary

The microcapillary glass slide, roughly the size and thickness of a penny, holds the protein samples.


The power of µSCALE is how it enables researchers to build upon current biochemical techniques to run a million protein experiments simultaneously, then extract and further analyze the most promising results.


The researchers first employ a process termed “mutagenesis” to create random variations in a specific gene. These mutations are inserted into batches of yeast or bacterial cells, which express the altered gene and produce millions of random protein variants.




A µSCALE user mixes millions of tiny opaque glass beads into a sample containing millions of yeast or bacteria and spreads the mixture on a microcapillary slide. Tiny amounts of fluid trickle into each tube, carrying individual cells. Surface tension traps the liquid and the cell in each capillary.


The slide bearing these million yeast or bacteria, and the protein variants they produce, is inserted into the µSCALE device. A software-controlled microscope peers into each capillary and takes images of the biochemical reaction occurring therein.


Once a µSCALE user identifies a capillary of interest, the researcher can direct the laser to extract the contents of that tube without disrupting its neighbors, using an ingenious method devised by Baer.


“The beads are what enable extraction,” Baer said. “The laser supplies energy to move the beads, which breaks the surface tension and releases the sample from the capillary.”


Thus µSCALE empties the contents of a single capillary onto a collector plate, where the DNA of the isolated cell can be sequenced and the gene variant responsible for the protein of interest can be identified.


“One of the unique features of µSCALE is that it allows researchers to rapidly isolate a single desired cell from hundreds of thousands of other cells,” said Bob Chen, a doctoral student in Cochran’s lab who wrote the software to examine and detect signs of interesting protein activity within the test tubes.


Promising variants can be collected and reprocessed through µSCALE to further evolve and optimize the protein.


“This is an exciting new tool to answer important questions about proteins,” Cochran said, likening µSCALE to the way that high-throughput tools for gene analysis have allowed researchers to unlock key features of biology underlying human disease.


Genesis and proofs

The project began five years ago when Baer and collaborator Ivan Dimov developed the first instrument. They showed how to identify cell types in a microcapillary array and extract a single capillary’s contents using glass beads and a focused laser.


About three years ago, Cochran and Baer joined forces to develop µSCALE for protein engineering, and the team devised three experiments to showcase µSCALE’s utility and flexibility.


In one experiment, researchers sifted through a protein library produced in yeast cells to select antibodies that bound most tightly to a cancer target. Antibodies with a high target-binding affinity are known to be effective against cancer.


In a second example, they engineered a bright orange fluorescent protein biosensor. Using µSCALE, they did this almost 10 times faster than previous methods. Such biosensors are often used as tags in a wide variety of biology experiments.


A third experiment, carried out with Stanford biochemistry Professor Daniel Herschlag, used µSCALE to improve upon a model enzyme.


“This system will allow us to explore the evolutionary and functional relationships between enzymes, guiding the engineering of new enzymes that can carry out novel beneficial reactions,” Herschlag said.


The Stanford team included graduate students Sungwon Lim and Arvind Kannan, postdoctoral scholar Spencer Alford and researcher Fanny Sunden.


Support for this work included a Wallace H. Coulter Translational Partnership Award, which made this pioneering interdisciplinary research possible.




– Credit and Resource –


Written by: Ramin Skibba


Provided by: Standford University




Process to Accelerate Protein Evolution

Tuesday, 22 September 2015

Targeting DNA

Protein-based sensor could detect viral infection or kill cancer cells.


Scientia — MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.


This system can be customized to detect any DNA sequence in a mammalian cell and then trigger a desired response, including killing cancer cells or cells infected with a virus, the researchers say.


DNA, Targeting DNA, Protein, cancer , Cells, MIT , biological , engineers , DNA sequence, green fluorescent protein, immune , enzyme , NTR, chromosomes


“There is a range of applications for which this could be important,” says James Collins, the Termeer Professor of Medical Engineering and Science in MIT’s Department of Biological Engineering and Institute of Medical Engineering and Science (IMES). “This allows you to readily design constructs that enable a programmed cell to both detect DNA and act on that detection, with a report system and/or a respond system.”






Collins is the senior author of a Sept. 21 Nature Methods paper describing the technology, which is based on a type of DNA-binding proteins known as zinc fingers. These proteins can be designed to recognize any DNA sequence.


“The technologies are out there to engineer proteins to bind to virtually any DNA sequence that you want,” says Shimyn Slomovic, an IMES postdoc and the paper’s lead author. “This is used in many ways, but not so much for detection. We felt that there was a lot of potential in harnessing this designable DNA-binding technology for detection.”


Sense and respond

To create their new system, the researchers needed to link zinc fingers’ DNA-binding capability with a consequence — either turning on a fluorescent protein to reveal that the target DNA is present or generating another type of action inside the cell.


The researchers achieved this by exploiting a type of protein known as an “intein” — a short protein that can be inserted into a larger protein, splitting it into two pieces. The split protein pieces, known as “exteins,” only become functional once the intein removes itself while rejoining the two halves.


Collins and Slomovic decided to divide an intein in two and then attach each portion to a split extein half and a zinc finger protein. The zinc finger proteins are engineered to recognize adjacent DNA sequences within the targeted gene, so if they both find their sequences, the inteins line up and are then cut out, allowing the extein halves to rejoin and form a functional protein. The extein protein is a transcription factor designed to turn on any gene the researchers want.


In this paper, they linked green fluorescent protein (GFP) production to the zinc fingers’ recognition of a DNA sequence from an adenovirus, so that any cell infected with this virus would glow green.


This approach could be used not only to reveal infected cells, but also to kill them. To achieve this, the researchers could program the system to produce proteins that alert immune cells to fight the infection, instead of GFP.


“Since this is modular, you can potentially evoke any response that you want,” Slomovic says. “You could program the cell to kill itself, or to secrete proteins that would allow the immune system to identify it as an enemy cell so the immune system would take care of it.”


Martin Fussenegger, a professor of biotechnology and bioengineering at the Swiss Federal Institute of Technology in Zurich, described this experiment as an “elegant proof of concept” that could lead to greatly improved treatments for viral infection.


“Sentinel designer cells engineered with the DNA sense-and-response system may one day be able to sense and eliminate viruses in our body. This would represent a quantum leap in antiviral therapy,” says Fussenegger, who was not involved in the study.


The MIT researchers also deployed this system to kill cells by linking detection of the DNA target to production of an enzyme called NTR. This enzyme activates a harmless drug precursor called CB 1954, which the researchers added to the petri dish where the cells were growing. When activated by NTR, CB 1954 kills the cells.




Future versions of the system could be designed to bind to DNA sequences found in cancerous genes and then produce transcription factors that would activate the cells’ own programmed cell death pathways.


DNA, Targeting DNA, Protein, cancer , Cells, MIT , biological , engineers , DNA sequence, green fluorescent protein,


Research tool

The researchers are now adapting this system to detect latent HIV proviruses, which remain dormant in some infected cells even after treatment. Learning more about such viruses could help scientists find ways to permanently eliminate them.


“Latent HIV provirus is pretty much the final barrier to curing AIDS, which currently is incurable simply because the provirus sequence is there, dormant, and there aren’t any ways to eradicate it,” Slomovic says.


While treating diseases using this system is likely many years away, it could be used much sooner as a research tool, Collins says. For example, scientists could use it to test whether genetic material has been successfully delivered to cells that scientists are trying to genetically alter. Cells that did not receive the new gene could be induced to undergo cell death, creating a pure population of the desired cells.


It could also be used to study chromosomal inversions and transpositions that occur in cancer cells, or to study the 3-D structure of normal chromosomes by testing whether two genes located far from each other on a chromosome fold in such a way that they end up next to each other, the researchers say.






– Credit and Resource –


Anne Trafton | MIT News Office




Targeting DNA